Stem Cells, Duchenne Muscular Dystrophy (DCM) & Cardiomyopathies

Conclusion: ADMs delay or prevent development of DCM in dystrophin-deficient heart, but timing of stem cell transplantation may be critical for achieving benefit with cell therapy in DMDcardiac muscle.Stem Cell Research Reagents.
Source: Neuromics - Category: Neuroscience Tags: Cardiomyopathy DCM ADMs Duchenne Muscular Dystrophy nestin antibodies Aorta-derived mesoangioblasts nestin antibody Stem cell markers cardiomyocytes Source Type: news